- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 231/24 - SeparationPurification
Patent holdings for IPC class C07C 231/24
Total number of patents in this class: 275
10-year publication summary
16
|
24
|
18
|
15
|
18
|
33
|
17
|
15
|
14
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
GE Healthcare AS | 224 |
21 |
Showa Denko K.K. | 2230 |
9 |
Les Laboratoires Servier | 542 |
8 |
Tate & Lyle Technology Limited | 205 |
7 |
BASF SE | 20933 |
6 |
Resonac Corporation | 2800 |
6 |
Newron Pharmaceuticals S.p.A. | 61 |
5 |
Zhejiang Huahai Pharmaceutical Co., Ltd. | 209 |
5 |
Supercritical Fluid Technologies, Inc. | 17 |
5 |
Mitsubishi Chemical Corporation | 4507 |
4 |
Teva Pharmaceutical Industries Ltd. | 789 |
4 |
Teva Pharmaceuticals USA, Inc. | 894 |
4 |
Novo Nordisk A/S | 2282 |
4 |
Anhui Jinhe Industrial Co., Ltd. | 88 |
3 |
Crystal PharmaTech Co., Ltd | 84 |
3 |
Geron Corporation | 165 |
3 |
Instituto Superior Tecnico | 152 |
3 |
Paratek Pharmaceuticals, Inc. | 109 |
3 |
Shanghai Institute of Pharmaceutical Industry | 129 |
3 |
UPL Limited | 582 |
3 |
Other owners | 166 |